FETAL PROGRAMMING AND THE DEVELOPMENT OF CARDIOMETABOLIC DISEASES: THE ROLE OF EPIGENETIC CHANGES
Health and Society · 12.06.2026 · 6 (03) · 38-62
DOI: 10.51249/hs.v6i03.3060 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health and Society, online erschienen am 12.06.2026. Verfasst von Isabela Da Silva Vieira und 8 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cardiometabolic diseases are among the leading causes of morbidity and mortality worldwide and are influenced not only by genetic and environmental factors during adulthood but also by exposures occurring during intrauterine life. In this context, the Developmental Origins of Health and Disease (DOHaD) theory highlights the importance of fetal programming in determining future disease risk. This study aimed to analyze the role of epigenetic alterations in fetal programming and their relationship with the development of cardiometabolic diseases throughout life. An integrative literature review was conducted following the PRISMA 2020 guidelines. Searches were performed in PubMed/MEDLINE, Scopus, Web of Science, Embase, and the Virtual Health Library using descriptors related to fetal programming, epigenetics, and cardiometabolic diseases. Articles published between 2020 and 2026 in English, Portuguese, and Spanish were included, resulting in a final sample of 17 studies after applying the eligibility criteria. The findings demonstrated that gestational factors such as maternal obesity, gestational diabetes, intrauterine growth restriction, and inadequate dietary patterns can induce persistent epigenetic modifications, including DNA methylation, histone alterations, and regulation by non-coding RNAs. These changes influence fetal gene expression and are associated with an increased risk of obesity, insulin resistance, metabolic syndrome, type 2 diabetes mellitus, and cardiovascular diseases in the offspring. Furthermore, the placenta was found to play a significant role in mediating maternal inflammatory and metabolic effects on fetal development. It is concluded that epigenetic mechanisms constitute a fundamental link between adverse gestational exposures and the future development of cardiometabolic diseases, highlighting the importance of preventive strategies focused on maternal health before and during pregnancy, as well as the need for further research to deepen the understanding of fetal programming processes.
Zitieren
APA
Vieira, I. D. S., Gonçalves, E. A., Santos, J. S., Giacomin, D. G., Freitas, L. N., Santos, M. C. D., Daflon, A. L. L. G., Oliveira, C. L. C., & Maio, F. M. A. (2026). FETAL PROGRAMMING AND THE DEVELOPMENT OF CARDIOMETABOLIC DISEASES: THE ROLE OF EPIGENETIC CHANGES. Health and Society, 6(03), 38-62. https://doi.org/10.51249/hs.v6i03.3060
Vancouver
Vieira IDS, Gonçalves EA, Santos JS, Giacomin DG, Freitas LN, Santos MCD, et al. FETAL PROGRAMMING AND THE DEVELOPMENT OF CARDIOMETABOLIC DISEASES: THE ROLE OF EPIGENETIC CHANGES. Health and Society. 2026;6(03):38-62. doi:10.51249/hs.v6i03.3060
BibTeX
@article{Vieira2026,
author = {Vieira, Isabela Da Silva and Gonçalves, Emily Amaral and Santos, Júlia Sander and Giacomin, Danieli Gomes and Freitas, Laura Nascimento and Santos, Mariana Costa dos and Daflon, Ana Luiza Latini Girolamy and Oliveira, Claudete Lúcia Carvalho and Maio, Fernanda Mazzelli Almeida},
title = {FETAL PROGRAMMING AND THE DEVELOPMENT OF CARDIOMETABOLIC DISEASES: THE ROLE OF EPIGENETIC CHANGES},
journal = {Health and Society},
year = {2026},
volume = {6},
number = {03},
pages = {38--62},
doi = {10.51249/hs.v6i03.3060}
}
EUVIMED